ATE323715T1 - Verfahren zur inaktivierung von prionen in lipoproteinen - Google Patents

Verfahren zur inaktivierung von prionen in lipoproteinen

Info

Publication number: ATE323715T1
Authority: AT; Austria
Prior art keywords: lipoprotein; prions; inactivation; lipoproteins; prion
Prior art date: 2001-05-08

Application number

AT01979600T

Other languages

English (en)

Inventor

Joseph G Montalto

Thomas M Mccall

Judith A Vollmer-Gash

Original Assignee

Serologicals Invest Company In

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-08

Filing date

2001-10-09

Publication date

2006-05-15

2001-10-09 Application filed by Serologicals Invest Company In filed Critical Serologicals Invest Company In

2006-05-15 Application granted granted Critical

2006-05-15 Publication of ATE323715T1 publication Critical patent/ATE323715T1/de

Links

102000004895 Lipoproteins Human genes 0.000 title abstract 4
108090001030 Lipoproteins Proteins 0.000 title abstract 4
102000029797 Prion Human genes 0.000 title abstract 3
108091000054 Prion Proteins 0.000 title abstract 3
230000002779 inactivation Effects 0.000 title abstract 2
230000002411 adverse Effects 0.000 abstract 1
230000004071 biological effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Analytical Chemistry (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT01979600T 2001-05-08 2001-10-09 Verfahren zur inaktivierung von prionen in lipoproteinen ATE323715T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US28963701P	2001-05-08	2001-05-08
US31497001P	2001-08-24	2001-08-24

Publications (1)

Publication Number	Publication Date
ATE323715T1 true ATE323715T1 (de)	2006-05-15

Family

ID=26965759

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01979600T ATE323715T1 (de)	2001-05-08	2001-10-09	Verfahren zur inaktivierung von prionen in lipoproteinen

Country Status (6)

Country	Link
US (2)	US6743899B2 (de)
EP (1)	EP1385871B1 (de)
AT (1)	ATE323715T1 (de)
AU (1)	AU2002211544A1 (de)
DE (1)	DE60118981D1 (de)
WO (1)	WO2002090379A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002211544A1 (en) *	2001-05-08	2002-11-18	Serologicals Royalty Company	Process for inactivating prions in lipoproteins
US20050054003A1 (en) *	2003-09-10	2005-03-10	Stenland Christopher J.	Prion clearance using particulate metal oxides
US20090118470A1 (en) *	2005-08-25	2009-05-07	Detlev Riesner	Prion Inactivation
US20070231202A1 (en) *	2006-03-31	2007-10-04	Roberts Charles G	method and system for prion inactivation
US8293174B2 (en)	2007-10-17	2012-10-23	American Sterilizer Company	Prion deactivating composition and methods of using same
CN119971148B (zh) *	2025-04-15	2025-07-11	卓阮医疗科技（苏州）有限公司	用于创面微环境愈合材料的组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3112249A (en)	1962-12-10	1963-11-26	Commw Engineering Co Of Ohio	Process of splitting steroids
US4290774A (en)	1980-01-07	1981-09-22	Miles Laboratories, Inc.	Purification of lipoprotein cholesterol for use as a cholesterol reference material
JPS61277623A (ja)	1985-05-10	1986-12-08	マイルス・ラボラトリ−ス・インコ−ポレ−テツド	哺乳動物の血漿または血清あるいはその分画からコレステロールに富んだ分画を単離しかつ精製する方法
AT408191B (de)	1991-08-19	2001-09-25	Haemosan Erzeugung Pharmazeuti	Verfahren zur inaktivierung von prionen
US5514388A (en) *	1994-08-31	1996-05-07	Rohwer; Gary L.	Encapsulated lipid-containing feed
US5756678A (en)	1995-05-01	1998-05-26	Cohesion Technologies, Inc.	Prion inactivation in connective tissue materials
ES2193499T3 (es)	1998-02-11	2003-11-01	Zlb Bioplasma Ag	Un metodo para la eliminacion de un agente o agentes causantes de encefalopatias espongiformes transmisibles de soluciones proteinicas.
AU2002211544A1 (en) *	2001-05-08	2002-11-18	Serologicals Royalty Company	Process for inactivating prions in lipoproteins

2001
- 2001-10-09 AU AU2002211544A patent/AU2002211544A1/en not_active Abandoned
- 2001-10-09 US US09/974,497 patent/US6743899B2/en not_active Expired - Lifetime
- 2001-10-09 DE DE60118981T patent/DE60118981D1/de not_active Expired - Lifetime
- 2001-10-09 AT AT01979600T patent/ATE323715T1/de not_active IP Right Cessation
- 2001-10-09 WO PCT/US2001/031505 patent/WO2002090379A1/en not_active Ceased
- 2001-10-09 EP EP01979600A patent/EP1385871B1/de not_active Expired - Lifetime
2004
- 2004-02-24 US US10/785,681 patent/US20040167071A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1385871A1 (de)	2004-02-04
EP1385871B1 (de)	2006-04-19
WO2002090379A1 (en)	2002-11-14
US6743899B2 (en)	2004-06-01
AU2002211544A1 (en)	2002-11-18
DE60118981D1 (de)	2006-05-24
WO2002090379A8 (en)	2003-03-20
US20030032780A1 (en)	2003-02-13
US20040167071A1 (en)	2004-08-26

Similar Documents

Publication	Publication Date	Title
ATE420947T1 (de)	2009-01-15	Gewebeimplant zur wiederherstellung von knorpelgewebe
ATE342278T1 (de)	2006-11-15	Verfahren zur behandlung von diabetes mittels kgf
DE69528475D1 (de)	2002-11-07	Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
ATE241358T1 (de)	2003-06-15	Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
DE69829625D1 (de)	2005-05-12	Verfahren und Vorrichtung zur Behandlung von Perfluorokohlenstoff
ATE235262T1 (de)	2003-04-15	Verfahren zum sterilisieren von produkten
ATE499103T1 (de)	2011-03-15	Verfahren zur behandlung von arzneimittelinduzierter peripherer neuropathie und verwandten krankheitsformen
DE69415100D1 (de)	1999-01-21	Vliesstoffgegenstand zur Behandlung von Oberflächen, Verfahren zur Herstellung und Verwendung davon
DE69624073D1 (de)	2002-11-07	Verfahren und Vorrichtung zur Behandlung von Abfällen mittels Vergasung
ATE230617T1 (de)	2003-01-15	Verfahren und methode zur behandlung von abfällen
DE69115921D1 (de)	1996-02-08	Verfahren zur behandlung und verwendung von abfallstoffen
DE69423164D1 (de)	2000-04-06	Verfahren und Vorrichtung zur biologischen Aufbereitung von wässerigen organischen Abfällen
DE69834693D1 (de)	2006-07-06	Zusammensetzung zur behandlung von elastischen polyurethanfasern und die damit behandelten fasern
DE69519937D1 (de)	2001-02-22	Polyamin-verbindungen zur behandlung von proliferativer erkrankungen
DE69107992D1 (de)	1995-04-13	Verfahren zur elektrolytischen Herstellung von Ozon und Vorrichtung dazu.
ATE323715T1 (de)	2006-05-15	Verfahren zur inaktivierung von prionen in lipoproteinen
DE60218153D1 (de)	2007-03-29	Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
DE69416445D1 (de)	1999-03-25	Verfahren zur Behandlung von klebrigem Baumwollfaden mit Enzymen
DE69308879D1 (de)	1997-04-17	Methode zur behandlung von abfallverbrennungsrückständen und deren verwendung als adsorptionsmittel
DE59808788D1 (de)	2003-07-31	Verfahren zur Behandlung von natürlichen oder synthetischen Polyamidfasermaterialien
DE69918322D1 (de)	2004-07-29	Verwendung von optisch reinem (r)-tofizopam zur behandlung und pravention von angststörungen
DE59509246D1 (de)	2001-06-13	Verfahren zum chemischen modifizieren von alkylgruppenhaltigen thermoplasten
DE69827387D1 (de)	2004-12-09	Verwendung von pramipexol zur behandlung von restless-legs-syndrom
ATE294584T1 (de)	2005-05-15	Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
EP0711159A4 (de)	1998-01-14	Verfahren und zusammensetzungen zur behandlung von asthma, arthereosklerose und entzuendlichen erkrankungen unter verwendung von optisch reinem (-)-zilenton

Legal Events

Date	Code	Title	Description
2006-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties